Clinical Application
Cervical cancer is a malignant tumor that seriously endangers women's health, and human papillomavirus (HPV) DNA testing is an important method for cervical cancer screening. At present, HPV testing is mainly performed by clinicians, but due to factors such as the knowledge level and policies, some people cannot be screened for cervical cancer in a timely and effective manner. Compared with traditional clinical sampling and testing, the results of HPV self-sampling testing have higher consistency, and have the advantages of strong privacy, comfort, less pain, and less cost, which increase the enthusiasm of women to participate in HPV screening.
At present, many countries attach great importance to HPV self-sampling, and strive to incorporate it into their national screening plans to increase the prevalence of HPV screening, thereby benefiting more women.
